<i>SETBP1</i> dysregulation in congenital disorders and myeloid neoplasms.

Oncotarget · 2017 · PMC5584301 · PMID 28881700

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the case of CNL, the CSF3R mutation status did not affect survival, whereas SETBP1 -mutated patients showed a trend toward refractoriness to treatment and shorter survival, especially when CSF3R mutations were co-expressed [ 86 , 105 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.